Cargando…

Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute Graft-versus-Host Disease

Detalles Bibliográficos
Autores principales: Karadimitris, Anastasios, Ripoll-Fiol, Carme, Guerra, Jose Costa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925712/
https://www.ncbi.nlm.nih.gov/pubmed/35309781
http://dx.doi.org/10.1097/HS9.0000000000000220
_version_ 1784670116938514432
author Karadimitris, Anastasios
Ripoll-Fiol, Carme
Guerra, Jose Costa
author_facet Karadimitris, Anastasios
Ripoll-Fiol, Carme
Guerra, Jose Costa
author_sort Karadimitris, Anastasios
collection PubMed
description
format Online
Article
Text
id pubmed-8925712
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-89257122022-03-18 Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute Graft-versus-Host Disease Karadimitris, Anastasios Ripoll-Fiol, Carme Guerra, Jose Costa Hemasphere Cellular and gene therapy - Section 4 Wolters Kluwer Health 2019-06-30 /pmc/articles/PMC8925712/ /pubmed/35309781 http://dx.doi.org/10.1097/HS9.0000000000000220 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Cellular and gene therapy - Section 4
Karadimitris, Anastasios
Ripoll-Fiol, Carme
Guerra, Jose Costa
Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute Graft-versus-Host Disease
title Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute Graft-versus-Host Disease
title_full Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute Graft-versus-Host Disease
title_fullStr Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute Graft-versus-Host Disease
title_full_unstemmed Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute Graft-versus-Host Disease
title_short Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute Graft-versus-Host Disease
title_sort invariant nkt cells as a platform for car immunotherapy and prevention of acute graft-versus-host disease
topic Cellular and gene therapy - Section 4
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925712/
https://www.ncbi.nlm.nih.gov/pubmed/35309781
http://dx.doi.org/10.1097/HS9.0000000000000220
work_keys_str_mv AT karadimitrisanastasios invariantnktcellsasaplatformforcarimmunotherapyandpreventionofacutegraftversushostdisease
AT ripollfiolcarme invariantnktcellsasaplatformforcarimmunotherapyandpreventionofacutegraftversushostdisease
AT guerrajosecosta invariantnktcellsasaplatformforcarimmunotherapyandpreventionofacutegraftversushostdisease